Dr. Hilla Ben Pazi is a senior pediatric neurologist with decades of clinical experience and a leader in telemedicine. She founded NeuroCan, the first Israeli teleneurology company delivering specialist care to they periphery. Since 2019, she has been the founder and CEO of Avertto, a groundbreaking medical device startup focused on addressing the "holy grail" of neurology—automated stroke detection. Dr. Ben Pazi remains at the forefront of innovative stroke monitoring technologies, committed to improving early intervention and making linger lives worth living. Dr. (MD) Hilla Benpazi A senior pediatric neurologist and telemedicine specialist with decades of experience in clinical studies and medical services, Hilla is co-founder and CEO of StrokeAlert LTD. Since 2019 StrokeAlert has been developing AverttoTM, the first monitoring system to detect stroke and generate automatic alerts to enable early intervention. Hilla is founder of the first tele-neurology company in Israel, providing specialist care to the periphery (2017, NeuroCan).